What defines a successful endpoint in ablating typical AFL when induced?

What defines a successful endpoint in ablating typical AFL when induced?

• A. No evidence of tachycardia during follow-up
• B. No longer inducible with isoprel and dobutamine
• C. Reduction in rhythm complexity
• D. Stabilization of ventricular rates

Answer: (B)

The successful endpoint in ablating typical atrial flutter (AFL) when induced is defined by the absence of inducibility under pharmacological stress, such as with isoproterenol and dobutamine. This assessment is vital because it confirms that the mechanism responsible for AFL has been effectively interrupted or eliminated through the ablation procedure. Testing the induced AFL with these agents helps determine whether the arrhythmia can be reinitiated, indicating whether the targeted reentrant circuit has been successfully disrupted. This endpoint is particularly critical, as the main goal of the ablation procedure is not just to eliminate the arrhythmia but to ensure that it cannot be triggered again by the typical factors that would normally induce it. In contrast, the other options focus on outcomes that do not necessarily confirm the eradication of the underlying arrhythmic mechanism. For example, simply observing no tachycardia during follow-up does not guarantee that AFL is fully resolved, as it might not have been tested under stress conditions that can induce it. Similarly, while a reduction in rhythm complexity may be indicative of partial success, it doesn't directly confirm that AFL cannot recur. Finally, the stabilization of ventricular rates can occur without addressing the underlying atrial flutter mechanism. Thus, demonstrating that

The successful endpoint in ablating typical atrial flutter (AFL) when induced is defined by the absence of inducibility under pharmacological stress, such as with isoproterenol and dobutamine. This assessment is vital because it confirms that the mechanism responsible for AFL has been effectively interrupted or eliminated through the ablation procedure. Testing the induced AFL with these agents helps determine whether the arrhythmia can be reinitiated, indicating whether the targeted reentrant circuit has been successfully disrupted.

This endpoint is particularly critical, as the main goal of the ablation procedure is not just to eliminate the arrhythmia but to ensure that it cannot be triggered again by the typical factors that would normally induce it. In contrast, the other options focus on outcomes that do not necessarily confirm the eradication of the underlying arrhythmic mechanism. For example, simply observing no tachycardia during follow-up does not guarantee that AFL is fully resolved, as it might not have been tested under stress conditions that can induce it. Similarly, while a reduction in rhythm complexity may be indicative of partial success, it doesn't directly confirm that AFL cannot recur. Finally, the stabilization of ventricular rates can occur without addressing the underlying atrial flutter mechanism. Thus, demonstrating that